Anti-PD-1/IL-7v (OSE)

N/A

Report date: 2025/02/14 11:13:20

Base Information

Drug NameAnti-PD-1/IL-7v (OSE)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-PD-1Anti-Interleukin-7

TargetsProgrammed cell death protein 1Interleukin-7

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOse Immunotherapeutics

China Registration ClassN/A

Develop Information

Active CompaniesOse Immunotherapeutics

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A